Robert

 

Day

Rob Day is the head of the International Division Oncology Commercial Office at Pfizer, where he leads the strategy and execution of the company's oncology portfolio across International global markets. He has a wealth of experience in the pharmaceutical industry, spanning 30 years and various roles in marketing, sales, and business development. He has worked in different regions and therapeutic areas, including neuroscience, cardiovascular, rare diseases, and immunology.

Rob is passionate about innovation and its role in delivering improving the lives of patients. He fosters a culture of empowerment, collaboration, and excellence among his teams and partners, and strives to overcome any obstacles that might hinder their success. He is also committed to enhancing the oncology patient journey and experience through improving access, outcomes, and education. He has played a leadership role in the transformation of the commercial organization from a product-centric approach to a more patient centred one, focused on providing the best outcomes possible for patients taking our medicines